Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Major Institutions Bet Big on Cleveland-Cliffs Stock

Robert Sasse by Robert Sasse
August 26, 2025
in Stocks
0
Cleveland-Cliffs Stock
0
SHARES
259
VIEWS
Share on FacebookShare on Twitter

Despite posting a quarterly loss, Cleveland-Cliffs Inc. is attracting significant capital from heavyweight institutional investors. Major financial players are making substantial moves into the steel producer’s equity, signaling a notable vote of confidence that counters prevailing market pessimism.

A Surge in Institutional Investment

Recent regulatory filings reveal a wave of aggressive buying from institutional funds. Leading the charge, Nuveen LLC established a major new position by acquiring over 1.1 million shares, an investment valued at approximately $9.4 million. This move was far from isolated.

Wexford Capital dramatically expanded its stake by a staggering 1,212 percent. Concurrently, UBS Asset Management increased its holdings by 22.9 percent during the fourth quarter. Even smaller firms joined the trend, with Twelve Points Wealth Management boosting its investment by more than 50 percent in the first quarter. This collective action by sophisticated money managers presents a powerful message to the broader market.

Should investors sell immediately? Or is it worth buying Cleveland-Cliffs?

Looking Beyond Short-Term Challenges

The rationale behind this bullish activity becomes clearer upon examining the company’s underlying performance. While Cleveland-Cliffs reported a quarterly loss of $0.50 per share, it simultaneously delivered robust revenue that significantly surpassed analyst forecasts. The company’s revenue reached $4.93 billion, demonstrating fundamental operational strength.

These institutional investors appear to be focusing on the long-term prospects of the integrated steel and iron ore producer. Its strategic positioning within the domestic steel market and its solid revenue base suggest that current weakness may be viewed as a potential entry point. In a sector rife with macroeconomic uncertainty, this coordinated accumulation of shares points to professional confidence in the company’s resilience and future recovery.

The critical question for other investors now is whether these major market players have identified a compelling value proposition that the wider market has yet to recognize.

Ad

Cleveland-Cliffs Stock: Buy or Sell?! New Cleveland-Cliffs Analysis from October 12 delivers the answer:

The latest Cleveland-Cliffs figures speak for themselves: Urgent action needed for Cleveland-Cliffs investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 12.

Cleveland-Cliffs: Buy or sell? Read more here...

Tags: Cleveland-Cliffs
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Repligen Stock

Repligen Stock: Navigating Divergent Signals in Biotech Markets

Lam Research Stock

Lam Research Shares Surge as Analysts Revise Targets Upward

Avis Budget Stock

Avis Budget Faces Mounting Pressure as Major Investors Retreat

Recommended

Banking Markets and money

WSFS Financials Quarterly Earnings Report and Investor Expectations

2 years ago

Yum Brands Faces Disappointment with Q4 Earnings

2 years ago
Tesla Stock

Tesla Stock: Futuristic Flops and Strategic Wins

2 months ago
Siemens Energy Stock

Siemens Energy Shares: Sustainable Recovery or Temporary Respite?

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Defense Stock Paradox: Record Orders Trigger Share Price Retreat

Idorsia Secures Strong Investor Backing in Oversubscribed Share Offering

Vulcan Energy Shares Face Pressure Following Shareholder Approval

BASF’s Landmark Deal: Strategic Masterstroke or High-Stakes Gamble?

ASML Navigates Leadership Transition Amid Geopolitical Headwinds

Danish Pharma Giant’s Contradictory Strategy Sparks Investor Concern

Trending

Precision BioSciences Inc Stock
Analysis

Precision BioSciences Stock Surges on Gene-Editing Breakthroughs

by Dieter Jaworski
October 12, 2025
0

Precision BioSciences Inc shares are demonstrating significant upward momentum, fueled by substantial advancements in its proprietary gene-editing...

Nel ASA Stock

Hydrogen Sector’s Crossroads: Nel ASA Navigates Industry Retreat and Government Push

October 11, 2025
Hoegh Autoliners ASA Stock

Norwegian Car Carrier Faces Mounting Headwinds as Shares Slide

October 11, 2025
Rheinmetall Stock

Defense Stock Paradox: Record Orders Trigger Share Price Retreat

October 11, 2025
Idorsia Stock

Idorsia Secures Strong Investor Backing in Oversubscribed Share Offering

October 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Precision BioSciences Stock Surges on Gene-Editing Breakthroughs
  • Hydrogen Sector’s Crossroads: Nel ASA Navigates Industry Retreat and Government Push
  • Norwegian Car Carrier Faces Mounting Headwinds as Shares Slide

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com